NanoViricides Inc. (NNVC)

[changes_iv]

Sometime ago the BigKahuna said the following:

Nanoviricides are currently binary: they either work in humans as they have in animals, or they don't. IMO, there is nothing in between. If they work in humans, then $10 billion will be leaving $40 billion on the table. Pharmassette went for $11 billion with one drug completing Phase 2 and ready for Phase 3. Do the math with that and 5 antiviral drugs plus 200 more in development.~ BigKahuna

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=91019400

That is a valuation of about $50 billion as it is right now!!!

Enter a 2nd generation of targeted nanoparticles. What diseases will they target? At this time we don't know that much about NanoViricides, Inc. 2nd generation of targeted drugs but that only allow us give free rein to our imagination!!! $100 billion, possible?

Nanoviricides is the shifting paradigm of antiviral drugs. Notice that, for example, ICPT (no products sold in the market) drug successfully interacts with the host cells to heal/improve on a condition of a vital organ, the liver. The now optimized FluCide candidate (as well as other drugs in the NNVC's pipeline) is agnostic to the host. FluCide will not care if you are young or old, a whale, a cow, a mouse, a salamander...a bee? If the host has a life-threatening virus, it destroys it, along with the debilitating and painful symptoms, in a matter of hours.

"...we are a company...with the ability to rapidly create drugs, and when I say rapidly create drugs I'm talking about weeks instead of years..." ~ Dr. Eugene Seymour, CEO Nanoviricides, Inc.

"by the way, I'm sure that when you think human trials for drugs you think of hundreds of millions of dollars and years of time, well in this case because the disease only lasts a week, two weeks,...that it is possible to complete human trials in the space of a few short months...four parts to the human trials" ~ Dr. Eugene Seymour, CEO Nanoviricides, Inc.

How soon could all this happen? This year, and continued growth the next year and the next. At this time NanoViricides, Inc. is laying down the tracks to clinical trials, from FDA review to market. We are not using "Big Pharma's track for "loaded mules". It is a track reserved for "flying horses"!!!

Get ready for Friday! Soon enough it will be Monday! More good news are ahead!!!